The proposed CMS rule changes Medicare Part D, impacting PBMs and enhancing transparency. Key insights for insurance professionals on compliance and stakeholder engagement.

Explore proposed Medicare Part D PBM regulations aiming to enhance transparency and accountability, reshaping drug pricing strategies and market dynamics.

Explore the CMS proposed rule to enhance Medicare Advantage operations, impacting PBMs with a focus on transparency and cost-sharing for low-income individuals.

Explore the imminent impacts of midterm elections on drug pricing, pharma reforms, and insurance strategies amid changing healthcare policies.

Explore how pharmacy benefit managers influence drug pricing and healthcare access. Understand their role in mail orders and emerging legislative actions.

Explore the shift in U.S. antitrust policy to settle cases with PBMs, impacting drug pricing, transparency, and healthcare costs for consumers.

Explore how CMS is regulating Pharmacy Benefit Managers under CAA 2026, seeking feedback on compensation models and data reporting requirements. Act by July 20, 2026!

Explore key Medicare Part D reforms targeting pharmacy benefit managers to enhance transparency and compliance. Engage in shaping vital regulatory changes.

Learn how the HELP Copays Act ensures copay assistance counts towards patient costs, protecting access to medications and financial stability.

Discover how PBM ownership by insurers influences Medicare drug costs and understand the implications for pharmacies and patient access.